Optimising vitamin D levels in patients with COVID-19.

Kaler, J; Hussain, A; Azim, D; Ali, S; Nasim, S

Kaler, J; Hussain, A; Azim, D; Ali, S; Nasim, S.

Kaler J; Xavier University School of Medicine, Oranjestad, Aruba.
Hussain A; Xavier University School of Medicine, Oranjestad, Aruba.
Azim D; Doctoral Candidate of HealthCare Administration, Franklin University, Ohio, United States.
Ali S; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Nasim S; Stony Brook University, New York, United States.

Hong Kong Med J ; 27(2): 154-156, 2021 04.

Article in English | MEDLINE | ID: covidwho-1168170

Subject(s)

COVID-19; Immunity, Innate; Vitamin D Deficiency; Vitamin D; COVID-19/diagnosis; COVID-19/epidemiology; COVID-19/immunology; COVID-19/prevention & control; Humans; Immunity, Innate/drug effects; Immunity, Innate/physiology; Protective Agents/metabolism; SARS-CoV-2; Severity of Illness Index; Vitamin D/blood; Vitamin D/metabolism; Vitamin D/pharmacology; Vitamin D Deficiency/diagnosis; Vitamin D Deficiency/metabolism; Vitamin D Deficiency/therapy; Vitamin D Deficiency/virology; Vitamins/blood; Vitamins/metabolism; Vitamins/pharmacology

Keywords

Vitamin D

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitamin D / Vitamin D Deficiency / COVID-19 / Immunity, Innate Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Hong Kong Med J Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google